3/24
05:13 pm
nuvb
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nuvation Bio Inc. - NUVB
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nuvation Bio Inc. - NUVB
3/21
05:15 pm
nuvb
NUVB Investors Have Opportunity to Join Nuvation Bio Inc. Fraud Investigation with the Schall Law Firm
Low
Report
NUVB Investors Have Opportunity to Join Nuvation Bio Inc. Fraud Investigation with the Schall Law Firm
3/21
11:16 am
nuvb
Is It Time To Reassess Nuvation Bio (NUVB) After Its Recent Share Price Swings [Yahoo! Finance]
Low
Report
Is It Time To Reassess Nuvation Bio (NUVB) After Its Recent Share Price Swings [Yahoo! Finance]
3/19
10:00 am
nuvb
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nuvation Bio Inc. - NUVB
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nuvation Bio Inc. - NUVB
3/17
05:33 pm
nuvb
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nuvation Bio Inc. - NUVB
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nuvation Bio Inc. - NUVB
3/17
04:55 pm
nuvb
Nuvation Bio to Present Pivotal IBTROZI® (Taletrectinib) Data in TKI-Naïve and TKI-Pretreated Patients with Advanced ROS1-Positive Non-Small Cell Lung Cancer at AACR 2026 [Yahoo! Finance]
Low
Report
Nuvation Bio to Present Pivotal IBTROZI® (Taletrectinib) Data in TKI-Naïve and TKI-Pretreated Patients with Advanced ROS1-Positive Non-Small Cell Lung Cancer at AACR 2026 [Yahoo! Finance]
3/17
04:35 pm
nuvb
Nuvation Bio to Present Pivotal IBTROZI® (Taletrectinib) Data in TKI-Naïve and TKI-Pretreated Patients with Advanced ROS1-Positive Non-Small Cell Lung Cancer at AACR 2026
Low
Report
Nuvation Bio to Present Pivotal IBTROZI® (Taletrectinib) Data in TKI-Naïve and TKI-Pretreated Patients with Advanced ROS1-Positive Non-Small Cell Lung Cancer at AACR 2026
3/13
03:27 pm
nuvb
RBC Capital Lifts PT on Nuvation Bio (NUVB) to $13 From $12 – Here's Why [Yahoo! Finance]
Low
Report
RBC Capital Lifts PT on Nuvation Bio (NUVB) to $13 From $12 – Here's Why [Yahoo! Finance]
3/13
09:12 am
nuvb
Kuehn Law Encourages Investors of Nuvation Bio Inc. to Contact Law Firm
Neutral
Report
Kuehn Law Encourages Investors of Nuvation Bio Inc. to Contact Law Firm
3/12
10:00 am
nuvb
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nuvation Bio Inc. - NUVB
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nuvation Bio Inc. - NUVB
3/10
04:03 pm
nuvb
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nuvation Bio Inc. - NUVB
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nuvation Bio Inc. - NUVB
3/6
02:21 pm
nuvb
Kuehn Law Encourages Investors of Nuvation Bio Inc. to Contact Law Firm
Low
Report
Kuehn Law Encourages Investors of Nuvation Bio Inc. to Contact Law Firm
3/4
11:48 am
nuvb
Nuvation Bio (NUVB) Generates $62.9M Annual Revenue Following Successful Erozi Launch [Yahoo! Finance]
Medium
Report
Nuvation Bio (NUVB) Generates $62.9M Annual Revenue Following Successful Erozi Launch [Yahoo! Finance]
3/4
08:30 am
nuvb
Nuvation Bio Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
Medium
Report
Nuvation Bio Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
3/4
07:35 am
nuvb
Nuvation Bio Transitions To Commercial Stage With Iptrozi And Safusidenib Progress [Yahoo! Finance]
Medium
Report
Nuvation Bio Transitions To Commercial Stage With Iptrozi And Safusidenib Progress [Yahoo! Finance]
3/3
04:09 pm
nuvb
Nuvation Bio Stock Up 130% This Past Year as One Fund Discloses $3 Million Buy [Yahoo! Finance]
Medium
Report
Nuvation Bio Stock Up 130% This Past Year as One Fund Discloses $3 Million Buy [Yahoo! Finance]
3/3
02:22 pm
nuvb
Nuvation Bio (NUVB) had its price target lowered by UBS Group AG from $10.00 to $7.00. They now have a "neutral" rating on the stock.
Low
Report
Nuvation Bio (NUVB) had its price target lowered by UBS Group AG from $10.00 to $7.00. They now have a "neutral" rating on the stock.
3/3
10:46 am
nuvb
Nuvation Bio (NUVB) had its price target raised by Royal Bank Of Canada from $12.00 to $13.00. They now have an "outperform" rating on the stock.
Medium
Report
Nuvation Bio (NUVB) had its price target raised by Royal Bank Of Canada from $12.00 to $13.00. They now have an "outperform" rating on the stock.
3/3
02:42 am
nuvb
Nuvation Bio outlines first-line IBTROZI growth strategy with 50-month median DOR amid expanding global partnerships [Seeking Alpha]
High
Report
Nuvation Bio outlines first-line IBTROZI growth strategy with 50-month median DOR amid expanding global partnerships [Seeking Alpha]
3/3
02:42 am
nuvb
Nuvation Bio Inc. (NUVB) Q4 2025 Earnings Call Transcript [Seeking Alpha]
High
Report
Nuvation Bio Inc. (NUVB) Q4 2025 Earnings Call Transcript [Seeking Alpha]
3/3
12:59 am
nuvb
Nuvation Bio (NUVB) Q4 2025 Earnings Transcript [Yahoo! Finance]
High
Report
Nuvation Bio (NUVB) Q4 2025 Earnings Transcript [Yahoo! Finance]
3/3
12:03 am
nuvb
Nuvation Bio Inc (NUVB) Q4 2025 Earnings Call Highlights: Strong Market Acceptance of Erozi ... [Yahoo! Finance]
High
Report
Nuvation Bio Inc (NUVB) Q4 2025 Earnings Call Highlights: Strong Market Acceptance of Erozi ... [Yahoo! Finance]
3/2
08:21 pm
nuvb
Nuvation Bio Q4 Earnings Call Highlights [Yahoo! Finance]
High
Report
Nuvation Bio Q4 Earnings Call Highlights [Yahoo! Finance]
3/2
04:22 pm
nuvb
Nuvation Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]
High
Report
Nuvation Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]
3/2
04:21 pm
nuvb
Nuvation Bio GAAP EPS of -$0.11 misses by $0.02, revenue of $41.9M beats by $4.4M [Seeking Alpha]
High
Report
Nuvation Bio GAAP EPS of -$0.11 misses by $0.02, revenue of $41.9M beats by $4.4M [Seeking Alpha]